Andaman & Nicobar Halts Paediatric Cough Syrup Use Amid Safety Concerns

The Andaman and Nicobar administration has issued a directive to stop the use of cough syrups for children under two years. This regulatory measure follows guidance from the DGHS and aims to ensure safe usage by reinforcing compliance with national health advisories concerning paediatric medication usage.

The Andaman and Nicobar administration has implemented a significant measure by issuing an advisory to halt the use of cough syrup for children under two years old, prioritizing the safety and well-being of its younger population. This decision follows a directive from the Director General of Health Services (DGHS), aligning with broader health recommendations.

Tuesday's meeting, chaired by Deputy Commissioner Arjun Sharma, involved stakeholders from various health sectors to reinforce the advisory's implementation. The discussions centered around ensuring regulatory vigilance and promoting the judicious use of cough medications, particularly in pediatric care, to align with safety standards and clinical evaluations.

Inspection teams will be established to oversee compliance, ensuring pharmacies and health facilities dispense these medications only under valid prescriptions. The initiative extends to community awareness campaigns to educate citizens on the necessity of medical consultation for children's medication, safeguarding public health and preventing misuse.